Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,153
archived clinical trials in
Gout

Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1101
mi
from
Midlothian, VA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1101
mi
from
Midlothian, VA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1111
mi
from
Richmond, VA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1111
mi
from
Richmond, VA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1196
mi
from
Virginia Beach, VA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1196
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1427
mi
from
Olympia, WA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1427
mi
from
Olympia, WA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1410
mi
from
Seattle, WA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1201
mi
from
Spokane, WA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1201
mi
from
Spokane, WA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1407
mi
from
Tacoma, WA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1407
mi
from
Tacoma, WA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
970
mi
from
Morgantown, WV
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
970
mi
from
Morgantown, WV
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
630
mi
from
Milwaukee, WI
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
630
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
8347
mi
from
Herston,
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
8347
mi
from
Herston,
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
853
mi
from
Phoenix, AZ
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1118
mi
from
La Jolla, CA
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1118
mi
from
La Jolla, CA
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1168
mi
from
Los Angeles, CA
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1168
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1329
mi
from
Stanford, CA
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1329
mi
from
Stanford, CA
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1299
mi
from
Boca Raton, FL
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1299
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
DeLand, FL
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1307
mi
from
Fort Lauderdale, FL
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1307
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1271
mi
from
Jupiter, FL
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1271
mi
from
Jupiter, FL
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
982
mi
from
Meridan, ID
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
982
mi
from
Meridan, ID
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
725
mi
from
Lexington, KY
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
725
mi
from
Lexington, KY
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1125
mi
from
Wheaton, MD
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1125
mi
from
Wheaton, MD
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
971
mi
from
Las Vegas, NV
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
971
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1188
mi
from
Reno, NV
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1188
mi
from
Reno, NV
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
965
mi
from
Harrisburg, NC
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
965
mi
from
Harrisburg, NC
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
726
mi
from
Cincinnati, OH
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
895
mi
from
Cleveland, OH
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
895
mi
from
Cleveland, OH
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
906
mi
from
Mayfield Village, OH
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
906
mi
from
Mayfield Village, OH
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
1388
mi
from
Durham, SC
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
1388
mi
from
Durham, SC
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
953
mi
from
Rock Hill, SC
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
953
mi
from
Rock Hill, SC
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
481
mi
from
Germantown, TN
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
481
mi
from
Germantown, TN
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
518
mi
from
Jackson, TN
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
518
mi
from
Jackson, TN
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
349
mi
from
Dallas, TX
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
349
mi
from
Dallas, TX
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
583
mi
from
San Antonio, TX
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
583
mi
from
San Antonio, TX
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
780
mi
from
West Jordan, UT
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
780
mi
from
West Jordan, UT
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
1185
mi
from
Chesapeake, VA
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
1185
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated:  1/23/2017
1472
mi
from
Coquitlam,
Allopurinol Combination Study
Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients With an Inadequate Hypouricemic Response With Standard Doses of Allopurinol
Status: Enrolling
Updated: 1/23/2017
1472
mi
from
Coquitlam,
Click here to add this to my saved trials
RDEA3170 Bioavailability Study
A Phase 1, Randomized, Open-Label, Crossover Study in Healthy Adult Male Subjects to Assess the Relative Bioavailability of Two RDEA3170 Tablets
Status: Enrolling
Updated:  10/9/2017
Clinical Research Facility
522
mi
from
Austin, TX
RDEA3170 Bioavailability Study
A Phase 1, Randomized, Open-Label, Crossover Study in Healthy Adult Male Subjects to Assess the Relative Bioavailability of Two RDEA3170 Tablets
Status: Enrolling
Updated: 10/9/2017
Clinical Research Facility
522
mi
from
Austin, TX
Click here to add this to my saved trials
The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
Status: Enrolling
Updated:  12/13/2017
University of Mississippi Medical Center General Medicine/Hypertension and Family Medicine Clinics
572
mi
from
Jackson, MS
The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
Status: Enrolling
Updated: 12/13/2017
University of Mississippi Medical Center General Medicine/Hypertension and Family Medicine Clinics
572
mi
from
Jackson, MS
Click here to add this to my saved trials
RDEA3170 and Allopurinol Combination Study in Gout Subjects
A Phase 1b, Randomized, Open-label Study to Evaluate the Potential Pharmacokinetic and Pharmacodynamic Interactions Between RDEA3170 and Allopurinol in Adult Male Subjects With Gout
Status: Enrolling
Updated:  12/19/2017
Clinical Research Facility
190
mi
from
Overland Park, KA
RDEA3170 and Allopurinol Combination Study in Gout Subjects
A Phase 1b, Randomized, Open-label Study to Evaluate the Potential Pharmacokinetic and Pharmacodynamic Interactions Between RDEA3170 and Allopurinol in Adult Male Subjects With Gout
Status: Enrolling
Updated: 12/19/2017
Clinical Research Facility
190
mi
from
Overland Park, KA
Click here to add this to my saved trials
Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
A Phase 2a, Randomized, Open-Label Study to Evaluate the Pharmacodynamic Effects and Safety of RDEA3170 Administered in Combination With Allopurinol Compared With Allopurinol Administered Alone in Adult Subjects With Gout
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
1157
mi
from
Anaheim, CA
Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
A Phase 2a, Randomized, Open-Label Study to Evaluate the Pharmacodynamic Effects and Safety of RDEA3170 Administered in Combination With Allopurinol Compared With Allopurinol Administered Alone in Adult Subjects With Gout
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
1157
mi
from
Anaheim, CA
Click here to add this to my saved trials
Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
A Phase 2a, Randomized, Open-Label Study to Evaluate the Pharmacodynamic Effects and Safety of RDEA3170 Administered in Combination With Allopurinol Compared With Allopurinol Administered Alone in Adult Subjects With Gout
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
DeLand, FL
Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
A Phase 2a, Randomized, Open-Label Study to Evaluate the Pharmacodynamic Effects and Safety of RDEA3170 Administered in Combination With Allopurinol Compared With Allopurinol Administered Alone in Adult Subjects With Gout
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
A Phase 2a, Randomized, Open-Label Study to Evaluate the Pharmacodynamic Effects and Safety of RDEA3170 Administered in Combination With Allopurinol Compared With Allopurinol Administered Alone in Adult Subjects With Gout
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
1320
mi
from
South Miami, FL
Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
A Phase 2a, Randomized, Open-Label Study to Evaluate the Pharmacodynamic Effects and Safety of RDEA3170 Administered in Combination With Allopurinol Compared With Allopurinol Administered Alone in Adult Subjects With Gout
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
1320
mi
from
South Miami, FL
Click here to add this to my saved trials
Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
A Phase 2a, Randomized, Open-Label Study to Evaluate the Pharmacodynamic Effects and Safety of RDEA3170 Administered in Combination With Allopurinol Compared With Allopurinol Administered Alone in Adult Subjects With Gout
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
349
mi
from
Dallas, TX
Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
A Phase 2a, Randomized, Open-Label Study to Evaluate the Pharmacodynamic Effects and Safety of RDEA3170 Administered in Combination With Allopurinol Compared With Allopurinol Administered Alone in Adult Subjects With Gout
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
349
mi
from
Dallas, TX
Click here to add this to my saved trials
Lesinurad and Febuxostat Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
683
mi
from
Birmingham, AL
Lesinurad and Febuxostat Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
Lesinurad and Febuxostat Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
848
mi
from
Tempe, AZ
Lesinurad and Febuxostat Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
848
mi
from
Tempe, AZ
Click here to add this to my saved trials
Lesinurad and Febuxostat Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1165
mi
from
Glendale, CA
Lesinurad and Febuxostat Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1165
mi
from
Glendale, CA
Click here to add this to my saved trials
Lesinurad and Febuxostat Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1162
mi
from
Huntington Beach, CA
Lesinurad and Febuxostat Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1162
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Lesinurad and Febuxostat Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1152
mi
from
Irvine, CA
Lesinurad and Febuxostat Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1152
mi
from
Irvine, CA
Click here to add this to my saved trials
Lesinurad and Febuxostat Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1143
mi
from
San Diego, CA
Lesinurad and Febuxostat Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
Lesinurad and Febuxostat Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
409
mi
from
Denver, CO
Lesinurad and Febuxostat Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
409
mi
from
Denver, CO
Click here to add this to my saved trials